PubMed چکیده/رکورد

Protein-based carriers for food bioactive delivery: gastrointestinal barriers, structural design, and bioavailability-oriented engineering.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Poor gastrointestinal stability and inefficient intestinal absorption remain major bottlenecks limiting the nutritional efficacy of food bioactives. Although protein-based carriers are widely investigated because of their edible origin, biodegradability, structural diversity, and tunable assembly behavior, many studies still emphasize material-level parameters rather than bioavailability-relevant performance. This review re-examines protein-based oral delivery systems through a gastrointestinal barrier-oriented framework. Representative carriers, including plant prolamins, legume globulins, oilseed and tuber proteins, albumins, milk proteins, fibrous proteins, ferritin cages, virus-like particles, elastin-like polypeptides, and silk fibroin, are discussed according to their structural features, assembly behavior, digestion fate, and delivery functions. Particular attention is given to how protein architectures can be engineered to improve gastric protection, protease resistance, mucus penetration, epithelial interaction, regional retention, and controlled release. Rather than treating protein source as the primary determinant of delivery performance, this review highlights carrier-barrier compatibility as the central design principle. Current evidence suggests that effective systems increasingly require integrated functions, including colloidal stability, food-grade manufacturability, safety, sensory compatibility, and measurable bioavailability enhancement. Future development should move beyond proof-of-concept encapsulation toward standardized digestion-absorption models, quantitative in vivo evaluation, and scalable processing strategies suitable for functional foods and dietary supplements.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

Controlled releaseFood bioactivesGastrointestinal fateOral bioavailabilityProtein-based carriersProtein-polysaccharide assemblies
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Chitosan-enhanced mucoadhesive delivery for local action: Salivary pharmacokinetic estimation.

BACKGROUND: Sore throat ache is a discomforting condition for patients during the disease course while eating, drinking or swallowing. However, improved topical concentration of locally acting drugs can address this issue. OBJECTIVES: The goal of the current research was to formulate and evaluate the single-dose salivary pharmacokinetics of a chitosan (CT)-based mucoadhesive delivery system containing tibezonium iodide and lignocaine (…

PubMed2026

Effect of diltiazem sustained-release capsules on cardiorenal composite outcomes in hypertensive patients with coronary heart disease: A real-world propensity score-matched study.

BACKGROUND: Hypertension frequently coexists with coronary heart disease (CHD) and integrated management is essential to reduce cardiovascular and renal complications. OBJECTIVES: To evaluate the efficacy and safety of add-on sustained-release diltiazem capsules in patients with hypertension and CHD. METHODS: This retrospective cohort analysis included 302 consecutive patients with CHD treated at the Affiliated Hospital of Jiangnan Uni…

PubMed2026

Preparation, characterization and in-vitro anti-cholestatic activity of swertiamarin-loaded galactosylated solid lipid nanoparticle.

BACKGROUND: Cholestatic liver injury (CLI) is a rapidly progressive liver disorder characterized by the accumulation of bile acids (BA). The therapeutic effects of current medicines used to treat CLI are unsatisfactory. OBJECTIVES: This study aimed to prepare galactosylated solid lipid nanoparticle (SLN) with swertiamarin (STM) by using a galactosylated lipid, N-hexadecyl lactobionamide (N-HLBA) and evaluate its anti-cholestasis effect…

PubMed2026

AI-guided data-driven kinetic modelling carbon quantum dot-enabled pH-responsive CMC/CeO2 nanocarriers for quercetin delivery and in vitro evaluation in lung cancer cells.

This work reports the development and systematic evaluation of a carboxymethyl cellulose (CMC)-based nanocarrier system co-loaded with cerium oxide (CeO2) and carbon quantum dots (CQDs) for pH-responsive delivery of quercetin (QC) and in vitro evaluation in lung cancer cells. The nanocarriers were prepared using a water-in-oil-in-water (W/O/W) double emulsion approach, yielding spherical particles with an average size of approximately …